Castleman Disease - 59 Studies Found
Recruiting |
: Specimen Collections From Patients With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer :
|
Terminated |
: Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection :
|
Recruiting |
: Unlock the Cell: Castleman's Disease Flow Cytometry Study :
|
Recruiting |
: Castleman Disease Collaborative Network Biobank :
|
Recruiting |
: International Registry for Patients With Castleman Disease :
|
Completed |
: 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis :
: Drug: tanespimycin |
Completed |
: Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials :
|
Active, not recruiting |
: A Study to Evaluate the Safety of Long-term Treatment With Siltuximab in Patients With Multicentric Castleman's Disease : Multicentric Castleman's Disease : 2011-04-21 : Drug: Siltuximab Type=exact number, unit=mg/kg, number=11, form=intravenous solution, route=intravenous. |
Completed |
: A Study to Provide RoActemra/Actemra (Tocilzumab) to Patients With Multicentric Castleman's Disease Who Demonstrated Benefit From Previous RoActemra/Actemra Treatment : Castleman's Disease : 2010-08-13 : Drug: tocilizumab [RoActemra/Actemra] maintenance dose |